Reuters logo
BRIEF-Mylan launches generic reclast injection
2017年6月2日 / 中午11点37分 / 6 个月前

BRIEF-Mylan launches generic reclast injection

June 2 (Reuters) - Mylan Nv

* Mylan launches generic reclast® injection

* Announced u.s. Launch of zoledronic acid injection, 5 mg/100 ml single dose vial, a generic version of novartis’ reclast® injection

* Mylan NV - received final approval from u.s. Fda for its abbreviated new drug application for zoledronic acid injection, 5 mg/100 ml single dose vial Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below